Published June 29, 2011, 05:00 PM
FDA panel: Revoke drug's breast cancer approval
SILVER SPRING, Md. — A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the government to remove its endorsement from the drug.By: Associated Press, INFORUM
RSS Feeds